诺和诺德（中国）制药有限公司于 1994 年成立，十余年来一直保持强劲增长。公司总部设在北京，建立了以北京、上海、广州、沈阳、武汉、济南以及香港为中心辐射全国的销售网络，产品服务遍及全国所有省市。

到 2006 年底，诺和诺德在华员工数将超过 1000 人。

诺和诺德公司是第一家在中国建立研发中心的生物制药公司，位于北京的研发中心是诺和诺德国际研发计划的组成部份，致力于与总部合作研发新产品及新生产程序。诺和诺德一直致力于将天津生产厂打造成国际化战略生产基地，对工厂的扩建进行了大量的投入，以便在满足国内市场的同时兼顾出口市场。

诺和诺德在中国的不断发展反映了公司对中国市场的承诺。我们坚信，中国的市场和研发工作在不久的将来一定会在全球居于领先地位。

Novo Nordisk in China
Since the establishment of Novo Nordisk ( China ) pharmaceuticals Co., Ltd. in 1994, the company's presence in China has grown dramatically. With headquarters in Beijing and local offices in Beijing , Shanghai , Guangzhou , Wuhan , Shenyang , Jinan an Hong Kong, the company is able to supply is innovative products and services to patients across the whole of China . The company will employ will employ over 1000 people in China by the end of 2006.

Novo Nordisk was the first biotech company to establish a R&D center in China . Situated in Beijing , the facility is part of our international R&D program for new products and processes. Ongoing investments in our manufacturing plant in Tianjin are developing. Novo Nordisk China , as a strategic manufacturing site for our company is able to supply both the local market as well as to export to other countries in the region.

These developments show our companies commitment to China and our belief that China will become one of the world's leading markets and centers for R&D in the future.